Cancer Treatment News and Research

RSS

National Inventors Hall of Fame picks winners at 2013 Collegiate Inventors Competition

An invention that strips cancer tumors' ability to hide from the body's immune system, and a better way to shock hearts back into their normal rhythm took top honors today at America's most prestigious collegiate inventing competition.

13 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.

13 Nov 2013

Novel discovery of RUNX3 gene provides new insights on defence mechanism against lung cancer

Novel discovery relating to the function of RUNX3 gene provides new insights on human defence mechanism against early stages of lung cancer development

13 Nov 2013

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema--a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.

13 Nov 2013

Specialist lung cancer nurses could aid treatment

A University research study has found that specialist lung cancer nurses could be putting patients in a stronger and healthier position to cope with the rigorous course of treatment that they undergo.

From Sheffield Hallam University 11 Nov 2013

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.

11 Nov 2013

Nutranomics provides update on GenEpic prostate cancer human clinical study

Nutranomics, Inc. is pleased to provide this update regarding the GenEpic prostate cancer human clinical study that is currently underway. Nutranomics has previously announced a non-binding Letter of Intent with Genesar Nutraceuticals, LLC with the intent of completing a licencing agreement to market and distribute GenEpic globally.

11 Nov 2013

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America- Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.

11 Nov 2013

A*STAR scientists discover potential target to weed out progression of cancer

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.

10 Nov 2013

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

The prostate gland produces part of the seminal fluid that protects sperm. It is located in front of the rectum and under the bladder, and surrounds the urethra, the tube through which urine flows from the bladder to and out of the penis.

6 Nov 2013

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

The go-to source for excellence in continuing medical education, Physicians' Education Resource®, LLC, will host the 11th Annual School of Breast Oncology November 7-10 at the Emory University Conference Center in Atlanta, GA.

6 Nov 2013

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).

6 Nov 2013

Next-generation sequencing may help discover genetic changes that might lead to cancer

A pilot study led by the Translational Genomics Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare shows that, even for patients with advanced and rapidly transforming cancer, researchers can find potential therapeutic targets using the latest advances in genomic sequencing.

31 Oct 2013

New study addresses general barriers inhibiting cancer research commercialization

A new study led by the University of Kentucky Markey Cancer Center Assistant Director for Research Nathan Vanderford cites a combination of factors that prevent academic-based cancer research faculty from ultimately commercializing their work.

31 Oct 2013

Immune Design closes Series C financing totalling up to $49M

Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced it has closed a Series C financing totalling up to $49 million.

30 Oct 2013

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

An experimental new cancer drug called MK-3475, which has shown dramatic promise for treating melanoma is also showing early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death of men and women worldwide.

30 Oct 2013

New unique nanostructure to target drug-delivery treatment of cancer cells

A unique nanostructure developed by a team of international researchers, including those at the University of Cincinnati, promises improved all-in-one detection, diagnoses and drug-delivery treatment of cancer cells.

29 Oct 2013

VisionGate's Cell-CT platform can detect lung cancer in sputum samples with high specificity

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT-, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer.

29 Oct 2013

Study confirms the "seed and soil" theory of metastasis

Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.

28 Oct 2013

Cancer Treatment News and Research

National Inventors Hall of Fame picks winners at 2013 Collegiate Inventors Competition

New biomedical instrument anticipated to help breakthroughs in animal, human health

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

Novel discovery of RUNX3 gene provides new insights on defence mechanism against lung cancer

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Specialist lung cancer nurses could aid treatment

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Nutranomics provides update on GenEpic prostate cancer human clinical study

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

A*STAR scientists discover potential target to weed out progression of cancer

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Next-generation sequencing may help discover genetic changes that might lead to cancer

New study addresses general barriers inhibiting cancer research commercialization

Immune Design closes Series C financing totalling up to $49M

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

New unique nanostructure to target drug-delivery treatment of cancer cells

VisionGate's Cell-CT platform can detect lung cancer in sputum samples with high specificity

Study confirms the "seed and soil" theory of metastasis

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News